BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33716733)

  • 1. Antagonizing αvβ3 Integrin Improves Ischemia-Mediated Vascular Normalization and Blood Perfusion by Altering Macrophages.
    Li Y; Gao Q; Shu X; Xiao L; Yang Y; Pang N; Luo Y; He J; Zhang L; Wu J
    Front Pharmacol; 2021; 12():585778. PubMed ID: 33716733
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of antagonizing RGD-binding integrin activity in papillary thyroid cancer cell lines.
    Cheng W; Feng F; Ma C; Wang H
    Onco Targets Ther; 2016; 9():1415-23. PubMed ID: 27042110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficiency of integrin αvβ3 inhibitor Cilengitide in acute cerebral ischemia in rats].
    Lu LQ; Fang T; Zhou D; Tong XX; Wu J; Yi L
    Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(7):559-64. PubMed ID: 26902199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled RGD uptake and alphav integrin expression is enhanced in ischemic murine hindlimbs.
    Lee KH; Jung KH; Song SH; Kim DH; Lee BC; Sung HJ; Han YM; Choe YS; Chi DY; Kim BT
    J Nucl Med; 2005 Mar; 46(3):472-8. PubMed ID: 15750161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic VEGF
    Ganta VC; Choi M; Farber CR; Annex BH
    Circulation; 2019 Jan; 139(2):226-242. PubMed ID: 30586702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction.
    Leblond P; Dewitte A; Le Tinier F; Bal-Mahieu C; Baroncini M; Sarrazin T; Lartigau E; Lansiaux A; Meignan S
    Anticancer Drugs; 2013 Sep; 24(8):818-25. PubMed ID: 23728220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cilengitide in osteoclast maturation and behavior.
    Chillà A; Bianconi D; Geetha N; Dorda A; Poettler M; Unseld M; Sykoutri D; Redlich K; Zielinski CC; Prager GW
    Exp Cell Res; 2015 Sep; 337(1):68-75. PubMed ID: 26209605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of α
    Grönman M; Tarkia M; Kiviniemi T; Halonen P; Kuivanen A; Savunen T; Tolvanen T; Teuho J; Käkelä M; Metsälä O; Pietilä M; Saukko P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
    J Transl Med; 2017 Jun; 15(1):144. PubMed ID: 28629432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MT1-MMP-Activated Liposomes to Improve Tumor Blood Perfusion and Drug Delivery for Enhanced Pancreatic Cancer Therapy.
    Wei Y; Song S; Duan N; Wang F; Wang Y; Yang Y; Peng C; Li J; Nie D; Zhang X; Guo S; Zhu C; Yu M; Gan Y
    Adv Sci (Weinh); 2020 Sep; 7(17):1902746. PubMed ID: 32995113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naoxintong restores collateral blood flow in a murine model of hindlimb ischemia through PPARδ-dependent mechanism.
    Chen L; Zhang L; Fang Z; Li C; Yang Y; You X; Song M; Coffie J; Zhang L; Gao X; Wang H
    J Ethnopharmacol; 2018 Dec; 227():121-130. PubMed ID: 30170078
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    López-Díez R; Shen X; Daffu G; Khursheed M; Hu J; Song F; Rosario R; Xu Y; Li Q; Xi X; Zou YS; Li H; Schmidt AM; Yan SF
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1536-1547. PubMed ID: 28642238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiopoietin-2 impairs collateral artery growth associated with the suppression of the infiltration of macrophages in mouse hindlimb ischaemia.
    Tan X; Yan K; Ren M; Chen N; Li Y; Deng X; Wang L; Li R; Luo M; Liu Y; Liu Y; Wu J
    J Transl Med; 2016 Oct; 14(1):306. PubMed ID: 27784306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance.
    Echavidre W; Durivault J; Gotorbe C; Blanchard T; Pagnuzzi M; Vial V; Raes F; Broisat A; Villeneuve R; Amblard R; Garnier N; Ortholan C; Faraggi M; Serrano B; Picco V; Montemagno C
    Cancer Res Commun; 2023 Dec; 3(12):2483-2496. PubMed ID: 38009896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shock wave treatment after hindlimb ischaemia results in increased perfusion and M2 macrophage presence.
    Tepeköylü C; Lobenwein D; Urbschat A; Graber M; Pechriggl EJ; Fritsch H; Paulus P; Grimm M; Holfeld J
    J Tissue Eng Regen Med; 2018 Jan; 12(1):e486-e494. PubMed ID: 27689683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Integrin αvβ3-Specific Ligand for the Sensitive Diagnosis of Glioblastoma.
    Zhang L; Shan X; Meng X; Gu T; Guo L; An X; Jiang Q; Ge H; Ning X
    Mol Pharm; 2019 Sep; 16(9):3977-3984. PubMed ID: 31306580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting αvβ3 and αvβ5 integrins inhibits pulmonary metastasis in an intratibial xenograft osteosarcoma mouse model.
    Gvozdenovic A; Boro A; Meier D; Bode-Lesniewska B; Born W; Muff R; Fuchs B
    Oncotarget; 2016 Aug; 7(34):55141-55154. PubMed ID: 27409827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of macrophage foam cell formation by alphaVbeta3 integrin: potential role in human atherosclerosis.
    Antonov AS; Kolodgie FD; Munn DH; Gerrity RG
    Am J Pathol; 2004 Jul; 165(1):247-58. PubMed ID: 15215180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-19 increases angiogenesis in ischemic hind limbs by direct effects on both endothelial cells and macrophage polarization.
    Richards J; Gabunia K; Kelemen SE; Kako F; Choi ET; Autieri MV
    J Mol Cell Cardiol; 2015 Feb; 79():21-31. PubMed ID: 25450612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative assessment of the effects of integrin inhibitor cilengitide on primary culture of head and neck squamous cell carcinoma (HNSCC) and HNSCC cell lines.
    Zhang L; Gülses A; Purcz N; Weimer J; Wiltfang J; Açil Y
    Clin Transl Oncol; 2019 Aug; 21(8):1052-1060. PubMed ID: 30632010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasion.
    Hoffmann S; He S; Jin M; Ehren M; Wiedemann P; Ryan SJ; Hinton DR
    BMC Ophthalmol; 2005 Jun; 5():16. PubMed ID: 15987521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.